NuSH
Metsera Secures $215 Million Series B Funding Following Promising Phase 1 Weight Loss Data
Metsera, Series B funding, weight loss, obesity treatment, GLP-1 drugs, NuSH peptides
Actionable Insights Powered by AI
Metsera, Series B funding, weight loss, obesity treatment, GLP-1 drugs, NuSH peptides